ezogabine has been researched along with Arrhythmia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, X; Fu, Y; Jia, Q; Mi, Y; Qi, J; Wang, K; Wu, Y; Xu, W; Zhang, D; Zhang, F; Zhang, H | 1 |
| Boehm, S; Dominguez-Rodriguez, M; Hilber, K; Koenig, X; Kovar, M; Kubista, H; Rubi, L; Todt, H; Zebedin-Brandl, E | 1 |
| Fretwell, LV; Woolard, J | 1 |
3 other study(ies) available for ezogabine and Arrhythmia
| Article | Year |
|---|---|
Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Cricetinae; Cricetulus; Drug Design; Epilepsy; Humans; KCNQ Potassium Channels; Patch-Clamp Techniques; Pyrazoles; Pyrimidines; Rubidium; Structure-Activity Relationship | 2011 |
Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.
Topics: Action Potentials; Animals; Anticonvulsants; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Carbamates; Cell Line; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ganglia, Sympathetic; Ganglionic Blockers; Guinea Pigs; Heart Conduction System; Heart Rate; Humans; Induced Pluripotent Stem Cells; Ion Channels; Isolated Heart Preparation; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Norepinephrine; Phenylenediamines; Potassium Channel Blockers; Rats, Sprague-Dawley; Risk Assessment; Time Factors; Transfection; Voltage-Gated Sodium Channel Blockers | 2017 |
Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Carbamates; CHO Cells; Coronary Circulation; Cricetulus; Dose-Response Relationship, Drug; Humans; Hypertension; KCNQ Potassium Channels; KCNQ2 Potassium Channel; Male; Membrane Transport Modulators; Phenylenediamines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Recombinant Proteins; Vasodilation | 2013 |